STERIS Other Income (Expense) decreased by 20.5% to -$15.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from -$16.50M to -$15.30M. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows an upward trend with a -14.1% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$43.30M | -$26.90M | -$20.52M | -$20.29M | -$23.44M | -$26.65M | -$30.47M | -$30.28M | -$30.98M | -$35.70M | -$36.87M | -$29.76M | -$10.30M | -$24.80M | -$16.50M | -$18.83M | -$14.10M | -$12.70M | -$15.30M |
| QoQ Change | — | +37.9% | +23.7% | +1.1% | -15.5% | -13.7% | -14.3% | +0.6% | -2.3% | -15.2% | -3.3% | +19.3% | +65.4% | -140.8% | +33.5% | -14.1% | +25.1% | +9.9% | -20.5% |
| YoY Change | — | — | — | — | +45.9% | +0.9% | -48.4% | -49.2% | -32.1% | -34.0% | -21.0% | +1.7% | +66.8% | +30.5% | +55.2% | +36.7% | -36.9% | +48.8% | +7.3% |